Do analysts prefer CERS or UTMD?

Cerus currently has a consensus price target of $4.00, suggesting a potential upside of 43.37%. Given Cerus' stronger consensus rating and higher probable upside, equities analysts plainly believe Cerus is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer UTMD or OSUR?

OraSure Technologies has a consensus price target of $3.00, indicating a potential downside of 28.06%. Given OraSure Technologies' higher probable upside, analysts plainly believe OraSure Technologies is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer UTMD or ANIK?

Anika Therapeutics has a consensus target price of $17.00, indicating a potential upside of 14.94%. Given Anika Therapeutics' higher probable upside, analysts clearly believe Anika Therapeutics is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Anika Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend UTMD or ALGN?

Align Technology has a consensus target price of $205.85, suggesting a potential upside of 22.32%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Align Technology 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.71

Utah Medical Products (UTMD) Competitors

$67.99 +2.46 (+3.75%)

Closing price 04:00 PM Eastern

Extended Trading

$67.48 -0.50 (-0.74%)

As of 04:10 PM Eastern

Compare

UTMD vs. CERS, OSUR, ANIK, WST, and ALGN

Should you buy Utah Medical Products stock or one of its competitors? MarketBeat compares Utah Medical Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), and Align Technology (ALGN). These companies are all part of the "health care supplies" industry.

How does Utah Medical Products compare to Cerus?

Cerus (NASDAQ:CERS) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Utah Medical Products has a net margin of 28.90% compared to Cerus' net margin of -4.41%. Utah Medical Products' return on equity of 9.13% beat Cerus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cerus	-4.41%	-15.18%	-4.38%
Utah Medical Products	28.90%	9.13%	8.86%

Cerus currently has a consensus price target of $4.00, suggesting a potential upside of 43.37%. Given Cerus' stronger consensus rating and higher probable upside, equities analysts plainly believe Cerus is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Cerus had 5 more articles in the media than Utah Medical Products. MarketBeat recorded 5 mentions for Cerus and 0 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.89 beat Cerus' score of 0.82 indicating that Utah Medical Products is being referred to more favorably in the news media.

Company	Overall Sentiment
Cerus	Positive
Utah Medical Products	Very Positive

Cerus has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.37, indicating that its stock price is 63% less volatile than the broader market.

Utah Medical Products has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerus	$206.13M	2.71	-$15.63M	-$0.05	N/A
Utah Medical Products	$38.52M	5.61	$11.29M	$3.38	20.12

78.4% of Cerus shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 5.6% of Cerus shares are held by company insiders. Comparatively, 8.0% of Utah Medical Products shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Utah Medical Products beats Cerus on 9 of the 16 factors compared between the two stocks.

How does Utah Medical Products compare to OraSure Technologies?

Utah Medical Products (NASDAQ:UTMD) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

OraSure Technologies has a consensus price target of $3.00, indicating a potential downside of 28.06%. Given OraSure Technologies' higher probable upside, analysts plainly believe OraSure Technologies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Utah Medical Products has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market.

Utah Medical Products has higher earnings, but lower revenue than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.61	$11.29M	$3.38	20.12
OraSure Technologies	$115.02M	2.50	-$68.73M	-$1.04	N/A

Utah Medical Products has a net margin of 28.90% compared to OraSure Technologies' net margin of -66.42%. Utah Medical Products' return on equity of 9.13% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
OraSure Technologies	-66.42%	-18.57%	-15.71%

In the previous week, OraSure Technologies had 3 more articles in the media than Utah Medical Products. MarketBeat recorded 3 mentions for OraSure Technologies and 0 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.89 beat OraSure Technologies' score of 0.90 indicating that Utah Medical Products is being referred to more favorably in the media.

Company	Overall Sentiment
Utah Medical Products	Very Positive
OraSure Technologies	Positive

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by company insiders. Comparatively, 3.9% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Utah Medical Products beats OraSure Technologies on 10 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to Anika Therapeutics?

Utah Medical Products (NASDAQ:UTMD) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

In the previous week, Anika Therapeutics had 1 more articles in the media than Utah Medical Products. MarketBeat recorded 1 mentions for Anika Therapeutics and 0 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.89 beat Anika Therapeutics' score of 0.94 indicating that Utah Medical Products is being referred to more favorably in the media.

Company	Overall Sentiment
Utah Medical Products	Very Positive
Anika Therapeutics	Positive

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by insiders. Comparatively, 12.1% of Anika Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Utah Medical Products has higher earnings, but lower revenue than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.61	$11.29M	$3.38	20.12
Anika Therapeutics	$112.82M	1.74	-$10.88M	-$0.79	N/A

Utah Medical Products has a beta of 0.37, indicating that its stock price is 63% less volatile than the broader market. Comparatively, Anika Therapeutics has a beta of 0.23, indicating that its stock price is 77% less volatile than the broader market.

Utah Medical Products has a net margin of 28.90% compared to Anika Therapeutics' net margin of -9.52%. Utah Medical Products' return on equity of 9.13% beat Anika Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
Anika Therapeutics	-9.52%	-5.90%	-4.52%

Anika Therapeutics has a consensus target price of $17.00, indicating a potential upside of 14.94%. Given Anika Therapeutics' higher probable upside, analysts clearly believe Anika Therapeutics is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Anika Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Utah Medical Products beats Anika Therapeutics on 9 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Utah Medical Products (NASDAQ:UTMD) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

Utah Medical Products has a net margin of 28.90% compared to West Pharmaceutical Services' net margin of 16.85%. West Pharmaceutical Services' return on equity of 19.03% beat Utah Medical Products' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Utah Medical Products	28.90%	9.13%	8.86%

In the previous week, West Pharmaceutical Services had 21 more articles in the media than Utah Medical Products. MarketBeat recorded 21 mentions for West Pharmaceutical Services and 0 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.89 beat West Pharmaceutical Services' score of 1.09 indicating that Utah Medical Products is being referred to more favorably in the news media.

Company	Overall Sentiment
West Pharmaceutical Services	Positive
Utah Medical Products	Very Positive

West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Utah Medical Products pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Utah Medical Products pays out 36.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Utah Medical Products has increased its dividend for 3 consecutive years. Utah Medical Products is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

West Pharmaceutical Services has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	7.27	$493.70M	$7.48	42.30
Utah Medical Products	$38.52M	5.61	$11.29M	$3.38	20.12

West Pharmaceutical Services currently has a consensus price target of $331.91, indicating a potential upside of 4.90%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, equities research analysts clearly believe West Pharmaceutical Services is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

West Pharmaceutical Services has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market.

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 8.0% of Utah Medical Products shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

West Pharmaceutical Services beats Utah Medical Products on 15 of the 20 factors compared between the two stocks.

How does Utah Medical Products compare to Align Technology?

Utah Medical Products (NASDAQ:UTMD) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Align Technology has a consensus target price of $205.85, suggesting a potential upside of 22.32%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

Utah Medical Products has a net margin of 28.90% compared to Align Technology's net margin of 10.50%. Align Technology's return on equity of 15.82% beat Utah Medical Products' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
Align Technology	10.50%	15.82%	10.17%

In the previous week, Align Technology had 5 more articles in the media than Utah Medical Products. MarketBeat recorded 5 mentions for Align Technology and 0 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.89 beat Align Technology's score of 0.76 indicating that Utah Medical Products is being referred to more favorably in the media.

Company	Overall Sentiment
Utah Medical Products	Very Positive
Align Technology	Positive

Align Technology has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.61	$11.29M	$3.38	20.12
Align Technology	$4.03B	2.99	$410.35M	$5.96	28.24

69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 8.0% of Utah Medical Products shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Utah Medical Products has a beta of 0.37, suggesting that its share price is 63% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, suggesting that its share price is 67% more volatile than the broader market.

Summary

Align Technology beats Utah Medical Products on 13 of the 17 factors compared between the two stocks.

Get Utah Medical Products News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UTMD vs. The Competition

Export

Metric	Utah Medical Products	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$216.21M	$8.25B	$6.44B	$12.46B
Dividend Yield	1.86%	2.61%	2.69%	5.22%
P/E Ratio	20.12	15.68	23.87	24.36
Price / Sales	5.61	7.13	521.52	117.06
Price / Cash	14.98	17.10	41.27	57.13
Price / Book	1.83	3.63	9.99	6.73
Net Income	$11.29M	$224.05M	$3.56B	$337.03M
7 Day Performance	2.60%	0.28%	-0.90%	0.08%
1 Month Performance	N/A	N/A	N/A	-1.78%
1 Year Performance	21.56%	2.90%	28.77%	33.98%

Utah Medical Products Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UTMD Utah Medical Products	1.3722 of 5 stars	$67.99 +3.8%	N/A	+17.0%	$216.21M	$38.52M	20.12	180	Positive News
CERS Cerus	2.8275 of 5 stars	$2.70 -4.9%	$4.00 +48.1%	+84.7%	$569.05M	$216.56M	N/A	290	News Coverage Short Interest Increase
OSUR OraSure Technologies	2.0265 of 5 stars	$4.00 -2.2%	$3.00 -25.0%	+33.4%	$281.59M	$115.02M	N/A	840
ANIK Anika Therapeutics	2.3456 of 5 stars	$14.38 -1.7%	$17.00 +18.2%	+24.3%	$194.66M	$112.82M	N/A	300
WST West Pharmaceutical Services	4.0139 of 5 stars	$312.77 -1.1%	$331.91 +6.1%	+50.2%	$22.35B	$3.07B	41.81	10,800	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UTMD) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Utah Medical Products (UTMD) Competitors

UTMD vs. CERS, OSUR, ANIK, WST, and ALGN

How does Utah Medical Products compare to Cerus?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Summary

How does Utah Medical Products compare to Align Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Utah Medical Products (UTMD) Competitors

UTMD vs. CERS, OSUR, ANIK, WST, and ALGN

How does Utah Medical Products compare to Cerus?

Is CERS or UTMD more profitable?

Do analysts prefer CERS or UTMD?

Does the media favor CERS or UTMD?

Which has more volatility and risk, CERS or UTMD?

Which has better earnings & valuation, CERS or UTMD?

Do insiders & institutionals have more ownership in CERS or UTMD?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Do analysts prefer UTMD or OSUR?

Which has more volatility & risk, UTMD or OSUR?

Which has preferable earnings & valuation, UTMD or OSUR?

Is UTMD or OSUR more profitable?

Does the media refer more to UTMD or OSUR?

Do institutionals & insiders believe in UTMD or OSUR?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Does the media refer more to UTMD or ANIK?

Do insiders & institutionals believe in UTMD or ANIK?

Which has stronger valuation & earnings, UTMD or ANIK?

Which has more volatility and risk, UTMD or ANIK?

Is UTMD or ANIK more profitable?

Do analysts prefer UTMD or ANIK?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Is WST or UTMD more profitable?

Does the media refer more to WST or UTMD?

Is WST or UTMD a better dividend stock?

Which has better valuation & earnings, WST or UTMD?

Do analysts prefer WST or UTMD?

Which has more volatility & risk, WST or UTMD?

Do insiders and institutionals hold more shares of WST or UTMD?

Summary

How does Utah Medical Products compare to Align Technology?

Do analysts recommend UTMD or ALGN?

Is UTMD or ALGN more profitable?

Does the media favor UTMD or ALGN?

Which has better earnings and valuation, UTMD or ALGN?

Do institutionals & insiders have more ownership in UTMD or ALGN?

Which has more volatility and risk, UTMD or ALGN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools